An Acupuncture Study for People At High Risk for Sepsis
NCT06344819 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2026-05-22
Summary
Researchers think acupuncture may improve outcomes for participants with sepsis, based on laboratory studies and previous studies in people with sepsis. The purpose of this study to see whether real acupuncture can improve outcomes for participants with sepsis when compared to sham acupuncture. Sham acupuncture is performed the same way as real acupuncture but will use different needles and target different sites or places on the body than real acupuncture.
Conditions
Interventions
- PROCEDURE
-
Acupuncture
Acupuncture involves insertion of thin filiform needles (gauze 30-40) at certain points on the body.
- OTHER
-
Sham Acupuncture
During sham acupuncture, the point on the participant's thigh 6 inches proximal to the ST36 acupuncture point is gently tapped with an acupuncture needle guide tube and an acupuncture needle is taped flat to the skin. This point is not on any acupuncture meridian or point.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Gary Deng, MD, PhD · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-20
- Primary Completion
- 2028-03-20
- Completion
- 2028-03-20
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Pilot Trial of External Warming in Septic Patients
NCT02706275 ·Status: COMPLETED ·Phase: NA
-
Repository for Sepsis and Postresuscitation Samples
NCT01670383 ·Status: RECRUITING
-
Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand
NCT02217592 ·Status: COMPLETED
-
Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis
NCT05999682 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observational Trial on Cytokine Adsorption in Sepsis
NCT04306419 ·Status: UNKNOWN
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study
NCT04288635 ·Status: RECRUITING
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
NCT04855786 ·Status: RECRUITING ·Phase: NA
-
Mitochondrial Function in Septic Patients
NCT03748537 ·Status: COMPLETED ·Phase: NA
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
NCT04103281 ·Status: RECRUITING
-
Sepsis and Myocarditis
NCT07079605 ·Status: RECRUITING
-
Shenfu Injection Improves Arterial Vascular Reactivity
NCT03749525 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Functionality of Endogenous Biological Clock in Sepsis
NCT04063332 ·Status: RECRUITING
-
Early Metabolic Resuscitation for Septic Shock
NCT03895853 ·Status: TERMINATED ·Phase: PHASE2
-
The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
NCT06898723 ·Status: RECRUITING ·Phase: PHASE4
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya
NCT02346331 ·Status: COMPLETED ·Phase: NA
-
Metrology to Enable Rapid and Accurate Clinical Measurements in Acute Management of Sepsis
NCT05338359 ·Status: UNKNOWN
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
NCT06548854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Transfusion-requirements in Septic Shock Trial
NCT01485315 ·Status: COMPLETED ·Phase: PHASE3
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED